Semaglutide Physician in Maryland
GLP-1: A Surprising Friend Against Cancer in Type 2 Diabetes?
New research suggests diabetes drugs known as GLP-1 receptor agonists (GLP-1) might protect against certain cancers. This study focused on type 2 diabetes patients and followed them for 15 years. It’s a surprising finding that could change cancer prevention for diabetes patients.
Published
Semaglutide’s Double Power for Weight Loss and Knee Pain
The study, Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis, explores the impact of weekly semaglutide injections. It focuses on weight loss and pain relief for people with obesity and knee osteoarthritis (OA)
Published
Eating Smart on GLP-1: 10 Strategies for Successful Weight Loss
The GLP-1 medications—like tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy)—have become powerful allies in weight loss. They work by reducing appetite, enhancing insulin response, and supporting a balanced metabolism. But to make the most of these treatments, eating smart is essential.
Published
Categorized as GLP1 agonist, Insights from Dr. Tashko, Insulin Resistance, Nutritional Guidance, Obesity Care, Weight Loss